Corrigendum to “Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: A feasibility study” [Gynecol. Oncol. 124 (2012) 78–82]
- 作者Emma C. Rossi; Anastasia Ivanova; John F. Boggess
- 卷第126卷
- 期第1期
- 印刷ISSN0090-8258
- 电子ISSN1095-6859
- 文件大小84.71KB
- 发表时间2012
- DOI10.1016/j.ygyno.2012.04.010
Sentinel Lymph Node Technique in Endometrial CancerStaley, Allison; Sullivan, Stephanie A.; Rossi, Emma C. · Obstetrical & Gynecological Survey · 2017
Sentinel Lymph Node Biopsy in Endometrial Cancer: a New Standard of Care?Sullivan, Stephanie A.; Rossi, Emma C. · Current Treatment Options in Oncology · 2017
Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: A feasibility studyEmma C. Rossi; Anastasia Ivanova; John F. Boggess · 2012
GEA 3162, a peroxynitrite donor, induces Bcl-2-sensitive, p53-independent apoptosis in murine bone marrow cellsEmma L. Taylor; John T. Li; Joan C. Tupper; Adriano G. Rossi; Robert K. Winn; John M. Harlan · 2007
Cytokine use and survival in the first-line treatment of ovarian cancer: A Gynecologic Oncology Group StudyFrederick B. Stehman; Mark F. Brady; J. Tate Thigpen; Emma C. Rossi; Robert A. Burger · 2012
Corrigendum to “Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: A feasibility study” [Gynecol. Oncol. 124 (2012) 78–82]Emma C. Rossi; Anastasia Ivanova; John F. Boggess · 2012